Research presented during WCLC 2022 shows patient-centered summaries may help potential participants to better understand the benefits and risks of clinical trials.

Experts evaluate available evidence comparing various strategies, including prophylactic cranial irradiation vs. surveillance, stereotactic radiosurgery vs. whole-brain radiotherapy, and more.

Experts reviewed data that show smoking can reduce innate immunity and suppress the efficacy of anti-cancer agents, leading to poorer outcomes for patients who continue to smoke after their cancer diagnosis.

The SHAWL study showed most women with lung cancer have little or no interest in sexual activity and experience increased pain and discomfort during sex following their diagnoses.

Advances in radiotherapy, robotic surgery, and artificial intelligence promise to change the practice of thoracic oncology.

Profession challenged to double survival rates within 5 years. Improving screening, reducing barriers to treatments will be key.

During a WCLC 2022 education session, experts reviewed the evidence for multiple treatment strategies in various patient populations.

A joint session at WCLC explored the impact the pandemic has had on the prevention, diagnosis, and management of thoracic malignancies.

While AI and machine learning are not likely to replace humans, ideally technology will enhance and expedite medical decision making.

The term “malignant mesothelioma” is no longer acceptable and should be replaced by “mesothelioma” for all uses, pathology researcher says.